Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis. - Wikidata - awgldk - TriplyDB

Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.

Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.

http://www.wikidata.org/entity/Q34979549

about

The Role of Neuropeptides in Mouse Models of Colitis The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.Histologic scoring indices for evaluation of disease activity in Crohn's disease.Potential roles of enteric glia in bridging neuroimmune communication in the gut.Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.

P2860

Q26773507-E430E19F-F5FB-465F-B4EA-A292C219E95D Q26774660-C5AAAB6E-013D-48E2-87C8-E62BCB21D9E5 Q35620108-4439476A-ED7C-434A-A7E7-7F14A587555B Q37054934-8E3EDB52-F4F5-4319-9DC2-75C6FC449D3A Q38668188-3A08A68D-56E3-426A-A55D-46885D0C5DDA Q39049151-DC1FEB5D-8780-4EB1-9513-FF946D166D52 Q39117205-7BC43C78-3DB7-4428-954B-3DEE40A5AB89 Q49885466-AF72313A-D0C1-4224-A06B-5FC55914B842

P2860

Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.

http://www.wikidata.org/entity/Q34979549

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@ast

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@en

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@nl

type

label

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@ast

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@en

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@nl

prefLabel

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@ast

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@en

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@nl

P1433

Q34979549-545DEED5-AF99-4E28-80C6-325DDD25B56A

P1476

Q34979549-EF7AB881-25E6-4257-A0CC-EDF55A854161

P2093

Q34979549-00DD6389-DFDF-428A-BB1C-4F18DCB9AA01

Q34979549-3E82CBE3-2DFF-4354-A75D-817A6DBDB4A3

Q34979549-D6445311-99F0-40DE-84A1-0754FE7257B6

Q34979549-E8AB452A-2D23-4720-9BFA-1349C49B9C84

P2860

Q34979549-0A82D5A6-7F06-4214-8E1C-A5B29126C926

Q34979549-0BEC0519-C4EE-4722-B37B-511E3855A832

Q34979549-17BB7743-039C-4BA6-8977-75C152E94EE2

Q34979549-20B3F3F7-D119-4DAA-8C65-6870DC476684

Q34979549-232546B9-3FAF-44CC-90DD-5C5833DC53E7

Q34979549-283946C6-715F-4B94-979E-EFAF2CD7C077

Q34979549-2D4E50CF-3CD0-4EC4-8A19-9BD461E8BB1D

Q34979549-2E59242A-06A0-4FAF-A873-39D9E074F51F

Q34979549-320CF6AE-DCD2-431B-BF27-04702EEDF18F

Q34979549-3E0D9EB3-C62A-48A6-984E-C6F617DD41AC

P304

Q34979549-9B1D5662-B235-406F-96EF-4CAE552F5523

P31

Q34979549-4AB2AC92-9881-466B-9301-2E122BF4379E

P356

Q34979549-AEB9C3C4-0E2D-449B-B844-DB2B14785E32

P433

Q34979549-B56857B4-DCD7-4540-84B4-FD5CCD2E8ECF

P478

Q34979549-AF7D300D-24BC-47B7-A661-4D8952B7A2D4

P577

Q34979549-E02D5352-2721-4650-A1E3-568B2FAA0B5F

P698

Q34979549-01F76C39-1122-49CB-80ED-BA948F33DEAF

P921

Q34979549-f39f613c-e67e-49a9-a52b-bb67b0819bca

P932

Q34979549-28BFCFEB-71B7-4D4A-AAA2-1E8FDDFDD51C

P356

P1433

Neuroimmunomodulation

P1476

Vasoactive intestinal peptide- ...... sulfonic acid-induced colitis.

@en

P2093

Anne-Claire Coûté-Monvoisin

http://www.w3.org/2001/XMLSchema#string

Catalina Abad

http://www.w3.org/2001/XMLSchema#string

Gardenia Cheung-Lau

http://www.w3.org/2001/XMLSchema#string

James A Waschek

http://www.w3.org/2001/XMLSchema#string

P2860

Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells

Crohn's disease

Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.

Th17-related cytokines: new players in the control of chronic intestinal inflammation

Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses.

Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.

The significance of vasoactive intestinal peptide in immunomodulation.

Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.

P304

203-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000364912

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25301381

http://www.w3.org/2001/XMLSchema#string

P921

P932

4297532

http://www.w3.org/2001/XMLSchema#string